Study

Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. – Cost Effective Supplements

Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/18204357


Conclusion of this study


Supplements analyzed in this study

Curcumin

Health conditions analyzed in this study

Mild Cognitive Impairment


Slightly Positive
Curcumin

Oxidative Damage


Slightly Positive
Curcumin


Functions related to this study

Antioxidant potential


Slightly Positive
Curcumin

Mental health


Slightly Positive
Curcumin


Body systems related to this study


Nervous System

Overall Systems
Scroll to top